This is a past event. Registration is closed. View other British Chamber of Commerce in Japan events.

With Japan facing increasing pressure to balance healthcare affordability with innovation, challenges such as drug lag and pricing policies are more critical than ever. As the global pharmaceutical landscape evolves and healthcare demands grow and technological advancements accelerate, Japan must navigate these issues to remain competitive and foster advancements in healthcare.

The BCCJ invites you to a timely lunchtime event on Thursday, February 6 at the AstraZeneca KK office, examining the current and future state of drug development and approval in Japan, and how this compares to the UK. Our panel of experts will explore how regulatory frameworks, innovation ecosystems, public-private partnerships, and international collaboration can address these pressing challenges and unlock new opportunities.


This event is designed for industry professionals, policymakers, researchers, and anyone interested in the future of healthcare in Japan and synergies in healthcare innovation between Japan and the UK.

Sponsors and Partners

Location

Tamachi AstraZeneca Japan
Minato City, Tokyo, Japan

Access:

1. Exit JR Tamachi Station:
Take the Shibaura Exit (East Exit).

2. Follow the Footbridge:
After exiting, follow the elevated footbridge walkway. You won’t need to go downstairs—the footbridge will lead you directly to the MSB Tamachi N Tower.

See route

Contact us

For additional event or venue information, please send an email to info@bccjapan.com